Skip to content

Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA

Quantitative Assessment of Lid Margin Vascularity Using Swept-source Optical Coherence Tomographic Angiography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06091722
Enrollment
150
Registered
2023-10-19
Start date
2023-10-20
Completion date
2024-02-28
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lid Margin Blood Flow Density, MGD, Ss-octa

Brief summary

To explore an optimized scan technique for the detection of lid margin vasculature

Detailed description

To investigate whether the SS-OCTA tool has the potential to characterize the lid margin vascularity in MGD patients. The repeatability and validity of OCTA in assessing eyelid margin blood flow density was evaluated。

Interventions

None listed

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

The MGD patients were aged \>\_20 years and were diagnosed according to Chinese MGD diagnostic criteria,11 including dry eye symptoms, and at least one of the following signs: (1) poor meibum expressibility or quality; (2) at least one of eyelid margin abnormalities (lid margin irregularity, plugging of the gland orifice, vascular engorgement/telangiectasia, and anterior replacement of the mucocutaneous junction. Normal subjects were defined as adults without any dry eye symptoms and lid margin abnormality.

Exclusion criteria

(1) subjects with ocular diseases or conditions known to affect the anatomy of the anterior segment, such as acute ocular inflammation, a history of eyelid surgery, contact lens wear within two weeks, and/or eyelid trauma; (2) subjects with of history of systemic or topical medications that might cause ocular congestion; (3) subjects with severe systemic illness or pregnancy; and (4) subjects who were difficult to cooperate with examination, resulting the obtained images were not sufficiently clear for automatic analysis.

Design outcomes

Primary

MeasureTime frameDescription
LMBFDImmediately after ssoctaLid margin blood flow density

Contacts

Primary ContactMan HU
64344308@qq.com13738069080

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026